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Introduction
Langerhans’ cell histiocytosis (LCH) is a rare disease of
still unknown aetiology despite extensive research
undertaken during recent decades. At present there are
some hypotheses in favour of a primarily reactive,
immunologically mediated origin, rather than a neo-
plastic process, but without any direct evidence of a viral
stimulus or strong genetic component [1, 2].
In a multicentre study we reviewed the clinical data
and radiological ﬁndings of 31 children being investi-
gated and treated for extra-osseous biopsy-proven LCH
between 1964 and 1999. There were 15 girls and 16 boys;
the male:female ratio was 1:1.1. Age at diagnosis ranged
from 3 months to 15 years (mean 2.8 years); 71%
(n=22) were 3 years old or less. All patients routinely
underwent radiographic skeletal survey, chest radiogra-
phy and abdominal US. CT and MRI were performed
according to the individual clinical indication, limited to
the areas of histiocytic inﬁltration.
In all children, extra-osseous LCH had been histo-
logically proven. Furthermore, the involvement of each
Sabine Schmidt
Georg Eich
Sylviane Hanquinet
Heinz Tscha¨ppeler
Peter Waibel
Franc¸ois Gudinchet
Extra-osseous involvement of Langerhans’
cell histiocytosis in children
Received: 25 August 2003
Accepted: 11 November 2003
Published online: 23 January 2004
 Springer-Verlag 2004
Abstract The predominant clinical
and radiological features of Langer-
hans’ cell histiocytosis (LCH) in ch-
ildren are due to osseous
involvement. Extra-osseous disease
is far less common, occurring in as-
sociation with bone disease or in is-
olation; nearly all anatomical sites
may be aﬀected and in very various
combinations. The following article
is based on a multicentre review of
31 children with extra-osseous LCH.
The objective is to summarise the
diverse possibilities of organ involv-
ement. The radiological manifesta-
tions using diﬀerent imaging
modalities are rarely pathognomonic
on their own. Nevertheless, famil-
iarity with the imaging ﬁndings, es-
pecially in children with systemic
disease, may be essential for early
diagnosis.
Keywords Langerhans’ cell
histiocytosis Æ Children
Pediatr Radiol (2004) 34: 313–321
DOI 10.1007/s00247-003-1118-z REVIEW
S. Schmidt (&) Æ F. Gudinchet
Departments of Radiology and
Interventional Radiology,
University Hospital Centre—CHUV,
Lausanne, Switzerland
E-mail: sabine.schmidt@chuv.hospvd.ch
Tel.: +41-21-3144435
G. Eich
Department of Paediatric Radiology,
Children’s Hospital, Zu¨rich, Switzerland
S. Hanquinet
Department of Paediatric Radiology,
Hoˆpital Cantonal, Geneva, Switzerland
H. Tscha¨ppeler
Department of Paediatric Radiology,
Children’s Hospital, Bern, Switzerland
P. Waibel
Department of Paediatric Radiology,
Children’s Hospital,
St. Gallen, Switzerland
individual organ was inferred from biopsy and/or
radiological ﬁndings.
Overview
Langerhans’ cells are histiocytes of the dendritic cell
lineage; they are deﬁned as a cell type that had been
recognised as a component of normal skin in the
middle of the nineteeth century [3, 4, 5]. Histopatho-
logically, LCH is characterised by a monoclonal
proliferation of abnormal Langerhans’ cells. This
proliferation is thought to reﬂect an immune response
to an as yet unknown antigenic stimulant [6]. These
Langerhans’ cells are capable of inﬁltrating almost any
tissue or organ. The gold standard for diagnosis is
electron microscopic study of the biopsy in which in-
tracytoplasmic Birbeck granules of the Langerhans’
cells are found; this is the only speciﬁc property of this
phenotype [2, 7]. Secondarily, immunohistochemistry
procedures are able to detect CD1 surface antigen on
lesional cells, a less speciﬁc marker, having also been
described in other histiocytic disorders such as rare
cases of juvenile xanthogranuloma and Rosai-Dorfman
disease (RDD) [2, 5]. The CD1a-positive cells can also
found in bronchoalveolar lavage with a score higher
than 5% [8, 9]. Finally, the positive stain of protein S-
100 is commonly used in the evaluation of histiocytic
disorders, although this is not a diagnostic marker on
its own [2].
With an annual incidence of 2–5/1,000,000 of the
paediatric population and a peak between 1 and 4 years
of age, LCH is considered to be a mainly childhood
disorder [1, 10]. The isolated pulmonary LCH seen in
adults is considered a separate entity since it is strongly
related to smoking, is polyclonal and frequently re-
gresses [2, 11, 12].
LCH in children shows a heterogeneous clinical
spectrum ranging from a single bone lesion to wide-
spread multisystem disease. The clinical course is also
very variable, mainly related to the patient’s age and
degree of organ dysfunction at the time of initial diag-
nosis. There has not yet been a generally accepted
prognostic factor or a completely satisfactory clinical
classiﬁcation [13, 14]. Fatal outcome is seen in dissemi-
nated LCH, often aﬀecting very young children (<2
years), and warrants aggressive therapy [1, 2, 10, 12, 15].
Plain radiography is the cornerstone of imaging of
LCH, since bone lesions predominate in the majority of
children. Osseous involvement has been described in the
literature in great detail [10, 16]. The various imaging
features of extra-osseous LCH, however, have been re-
ported less often. They are often limited to isolated case
reports [17, 18, 19, 20], or to single-organ involvement
[21, 22, 23, 24, 25]. The objective of our descriptive
analysis is to summarise the diverse radiological mani-
festations of the disease and to give an overview of the
diﬀerent imaging modalities now available to delineate
disease extension.
Study population
We categorised the 31 children in our study into two
groups: uni- or multifocal extra-osseous LCH. The fre-
quency of involvement of the diﬀerent organs, including
proof by biopsy, can be seen in Table 1. Eleven children
(35.5%) demonstrated unifocal extra-osseous LCH, ﬁve
(16%) patients presented with disease in two organs, 11
(35.5%) with three, and four (14%) with four diﬀerent
organs inﬁltrated by LCH. Twenty-three (75%) of the 31
children showed extra-osseous and skeletal lesions
simultaneously, of whom 19 (61%) had multifocal bone
disease.
Thirty of 31 patients received systemic chemotherapy,
two receiving additional radiation therapy for soft-tissue
inﬁltration. One child had medical treatment only for
diabetes insipidus.
Appropriate follow-up was available in 26 (84%)
children; 19 (73%) demonstrated regression of clinical
symptoms conﬁrmed by radiological improvement
without any major sequelae. Stable disease with signiﬁ-
cant organ dysfunction persisted in 5 (19%). Two chil-
dren (8%) died from active disease.
Table 1 Frequency of organ
involvement by extra-osseous
LCH in 31 children, including
proof by biopsy (CSF cerebral
spinal ﬂuid, LCH Langerhans’
cell histiocytosis)
Organ No of children
(n=31)
Unifocal
extra-osseous
LCH
Multifocal
extra-osseous
LCH
Individual proof
by biopsy
Skin 17 (55%) 2 15 17
Brain 11 (35%) 4 7 3 (CSF)
Liver/biliary system/spleen 10 (32%) 10 7
Lung 8 (26%) 2 6 2
Soft-tissue mass 8 (26%) 1 7 6
Lymphadenopathy 8 (26%) 2 6 6
Bone marrow 6 (19%) 6 6
Parotid glands 2 (6%) 2 2
Gastrointestinal tract 2 (6%) 2 2
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Radiological findings
Central nervous system
CerebralLCHwasseenin11(35%)ofour31children,always
following clinical symptoms of diabetes insipidus and
radiologically characterised by inﬁltration of the pituitary
gland (Fig. 1). In three childrenwealsoobserved contrast-
enhancingnodulesinthetemporallobes,ponsorcerebellum
on MRI. One child showed orbital and paranasal sinus
inﬁltration (Fig. 2) associated with osseous destruction.
Chronic pituitary gland insuﬃciency occurred in all nine
childrenwithadequatefollow-up,althoughtheradiological
ﬁndingsregressed.
MRI is currently the modality of choice to detect
cerebral LCH as well as involvement of the facial and
extracranial soft tissues; the latter is often associated
with adjacent osseous destruction. Pathologically, pro-
liferation of the adventitial cells of blood vessels
initially creates perivascular foci of Langerhans’ cells.
They later coalesce to granulomatous masses [26],
which can be identiﬁed radiologically as cerebral,
meningeal or spinal cord lesions. Brain parenchymal
lesions may simply show demyelination and gliosis [22].
Involvement of the CNS is seen in 25–35% of cases
during the course of disease, most often occurring in
multisystem LCH [22, 27]. Thirty-ﬁve percent of our
patients were thus aﬀected, the majority with dissemi-
nated disease. The most common cerebral site is the
hypothalamic-neurohypophyseal region [18, 27, 28],
conﬁrmed by our study. Radiological ﬁndings have
been proven to correlate with clinical symptoms of
diabetes insipidus [27]. Typically, they lead to lack of
the normal neurohypophyseal high signal seen on T1-
weighted (T1-W) MRI, frequently in association with a
thickened and gradually enhancing pituitary stalk
without wash-out (Fig. 1) [27, 28]. However, dynamic
MRI has not proven useful for the diﬀerential diagnosis
between LCH and other lesions, such as infundibular
germ cell tumours [28].
The second-most-common site of CNS involvement is
the cerebellum [29]. On MRI, cerebral parenchymal
inﬁltration is characterised by small nodules, isointense
on T1-W, iso- or mildly hyperintense on T2-W images
and mostly enhancing after IV gadolinium [18, 22]. Very
rarely, nodular meningeal thickening, spinal cord [30] or
nerve root inﬁltration can be seen [31], and there is one
biopsy-proven case report of histiocytic granuloma of
the choroid plexus [32].
Salivary glands
Histiocytic inﬁltration of parotid glands was histologi-
cally proven in two of our patients and was detectable as
bilateral symmetrical hyperplasia on US (Fig. 3a) and
CT (Fig. 3b). In one case there was also involvement of
submandibular glands. LCH of the parotid gland is
extremely rare. We are unaware of any previous publi-
cation concerning children; there has been only one
report of an adult heavy smoker [24]. Lieberman et al.
[33] described involvement of parotid-associated lym-
phoid tissue. In our cases, chemotherapy was successful,
the size of the parotid glands returning to normal
(Fig. 3c) and there being no recurrence.
Fig. 1a, b Cerebral MRI in a 1-year-old boy with diabetes
insipidus owing to LCH shows nodular thickening and enhance-
ment of the pituitary stalk on sagittal (a) and coronal (b) T1-W
spin-echo sequences after IV gadolinium
Fig. 2a, b A 3-year-old boy
with systemic extra-osseous
LCH. a Coronal and b sagittal
T1-W spin-echo MRI after IV
gadolinium demonstrate diﬀuse
histiocytic inﬁltration of both
orbital cavities extending into
the paranasal sinuses and
nasopharynx with osseous
destruction
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Thymus
There was no patient in our study with biopsy-proven
histiocytic inﬁltration of the thymus or alteration on
imaging modalities. Radiological ﬁndings have been re-
ported infrequently in small series, but unfortunately
they have lacked histological proof [17, 21, 34]. It is
always associated with multisystem LCH [21], usually
pulmonary involvement [34]. Thymus gland involvement
is probably more common than previously recognised
[35]. Radiologically, it is characterized by diﬀuse
enlargement with smooth or lobulated contour. CT may
demonstrate cystic spaces corresponding to focal
destructive lesions and serpentine calciﬁcations of vas-
cular or dystrophic origin [21, 34]. In general, treatment
leads to complete regression, including the calciﬁed and
cystic areas. The main diﬀerential diagnosis is thymic
rebound hyperplasia, i.e. transient thymic enlargement
in a patient completing chemotherapy and resolving
without further treatment.
Lungs
Pulmonary involvement occurs in 23–50% of children
with LCH, similar to our study (n=8, 26%), and
always as part of multisystem disease [24, 36, 37], also
conﬁrmed by our evaluation. When radiological
ﬁndings and clinical symptoms are moderate and
underlying LCH has already been recognised, proof by
biopsy or bronchoalveolar lavage is not deemed neces-
sary [23, 36].
In our eight patients, chest radiography demonstrated
a uniform reticulonodular interstitial pattern. Two
patients showed focal disease which regressed with che-
motherapy. In the other six cases the radiological ﬁndings
were diﬀuse; four evolved to chronic lung abnormalities
and one of these died. Evolution in one 2-year-old boy
was so aggressive that he required emergency treatment
for acute hypoxia within 1 month of the diagnosis being
established. Chest CT (Fig. 4a, b) revealed diﬀuse pul-
monary emphysema and ﬁbrosis complicated by pneu-
mothorax, pneumomediastinum and subcutaneous
emphysema extending as far as the scrotum.
Pathologically, histiocytic proliferation in the wall of
the bronchioles and alveolar ducts causes destructive
granulomas [38]. They are seen as pulmonary interstitial
disease evolving from a reticulonodular to a honeycomb
pattern on conventional chest radiography. Cavitation of
these nodules leads to air trapping and airway obstruc-
tion, resulting in pulmonary cysts. Rarely, rupture of
peripherally situated cysts results in spontaneous pneu-
mothorax, which can become a life-threatening problem
[36]. However, the very extensive bullous lesions we
illustrate in Fig. 4 occur very infrequently. Pneumomed-
iastinum might be associated, as was seen in our case,
while pleural eﬀusions and hilar or mediastinal lymph-
adenopathy is not common [38, 39], conﬁrmed by our
series of patients. Diﬀuse emphysema associated with
pulmonary ﬁbrosis is the end stage of thismixed restrictive
and obstructive pattern [5, 23, 25, 36, 40, 41] (Fig. 4c–f).
High-resolution CT (HRCT) is the superior imaging
modality for delineating nodules and cysts as well as the
extent of disease [42]. It represents an excellent non-
invasive means for diagnosis and follow-up of pulmo-
nary LCH [43]. At the same time, HRCT is a substitute
for monitoring the evolution in very young children too
small for reliable respiratory function testing (RFT).
Children are initially often asymptomatic; therefore,
clinical ﬁndings are not helpful in the early detection of
lung involvement by LCH [23, 36]. Conventional chest
radiography might not show subtle ﬁndings when RFT
are already abnormal [36], since histiocytic pulmonary
inﬁltration gradually progresses [9]. HRCT can then be
diagnostic. Typical ﬁndings of LCH, such as micro-
nodules and/or thin-walled small cysts with irregular
contour are easily detected [36, 42, 44]. They are bilateral
and symmetrical, the cysts show slight upper-lobe pre-
dominance with relative sparing of the costophrenic
angles. The main diﬀerential diagnoses of the HRCT
ﬁndings are lymphangioleiomyomatosis, emphysema
and cystic bronchiectasis.
Fig. 3 a Cervical US of a
3-year-old boy demonstrates
bilateral symmetrical enlarge-
ment of the parotid glands,
conﬁrmed by CT (b) and owing
to diﬀuse histiocytic inﬁltration.
c After chemotherapy size re-
turned to normal 20 months
later
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The diﬀuse interstitial and reticulonodular pattern
seen on conventional chest radiography results from a
summation of nodules and thin cystic walls [44].
According to Smets et al. [23] and Ha et al. [36], lung
involvement by LCH does not adversely aﬀect outcome,
provided that treatment is adequate. Nevertheless,
Bernstrand et al. [37] stressed that abnormal radiological
ﬁndings, such as cysts, emphysema and/or ﬁbrosis,
persisted in 24% of patients with initial pulmonary LCH
at long-term follow-up; however, the majority are or
were smokers [37]. Possible toxicity of treatment on
lungs might also lead to important sequelae and needs to
be taken into consideration [23]. In our study, four of
eight children with pulmonary involvement showed
persistent lung abnormalities; one demonstrated slowly
progressive lung emphysema after 5 years of follow-up
(Fig. 4e, f).
Hepatobiliary system, spleen and gastrointestinal tract
Fifty to sixty percent of children with LCH demonstrate
liver involvement, deﬁned as hepatomegaly with or
without liver dysfunction [45]. This is mostly a feature of
multisystem disease, as conﬁrmed by our study. The
majority of our patients also had splenomegaly.
Hepatobiliary involvement by LCH was seen in 10
(32%) out of our 31 patients, the initial radiological
ﬁndings being hepatosplenomegaly detected on abdom-
inal US. In 4 children there was only moderate and
homogeneous organ enlargement, returning to normal
size after chemotherapy. In the other 6 patients we ob-
served heterogeneous liver parenchyma on US and CT,
with nodular and periportal hypoechogenicities or hyp-
odensities corresponding to focal histiocytic inﬂamma-
tion (Fig. 5a). Biopsy revealed septal ﬁbrosis and even
biliary cirrhosis in 3 children with irregular segmental
stenosis of bile ducts alternating with areas of dilatation.
In 2, retrograde cholangiography demonstrated features
of sclerosing cholangitis (Fig. 6). One of the three chil-
dren with cirrhosis died, another underwent successful
liver transplantation, while the third could not be fol-
lowed up since parents refused liver transplantation.
Hepatosplenomegaly as well as focal liver lesions in the
other patients gradually regressed with chemotherapy
(Fig. 5b). However, follow-up CT at 5 years demon-
strated recurrence of liver hypodensities in one patient
(Fig. 5c).
Histologically, hepatic involvement by LCH is char-
acterised by periportal histiocytic inﬁltration evolving in
four phases: from an initial proliferative phase to a
granulomatous, xanthomatous and ﬁnally to a ﬁbrous
phase [46, 47]. Hepatomegaly and the diﬀerent stages
can be well depicted on US, CT and MRI [5, 45, 48, 49,
50]. Periportal hypoechoic changes correspond to hyp-
odensities on CT and to moderate-to-high intensities on
T2-W MRI, reﬂecting the proliferative and granuloma-
Fig. 4a–f Lung involvement by LCH in the same 3-year-old boy as
in Fig. 3. a, b Chest CT performed as an emergency depicts
multiple air-ﬁlled cysts and reticulonodular changes associated with
acute spontaneous left anterolateral pneumothorax, pneumomed-
iastinum and subcutaneous emphysema. c, d HRCT 20 months
later. There is persisting lung emphysema with ﬁbrosis characte-
rising the chronic destruction of pulmonary parenchyma with
regression of the acute involvement. e, f Follow-up by chest CT
after a further 40 months shows slow, but irreversible progression
of the lung emphysema without any acute complications
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tous phases. They result from inﬁltration by histiocytes
and other inﬂammatory cells surrounded by oedema.
Periportal contrast enhancement is then seen, suggesting
portal triaditis. Subsequent change to hyperechoic
nodules, which are composed of fat, occurs as a result of
evolution into the xanthomatous phase. They remain
hypodense on CT, while on MRI this stage is charac-
terised by hyperintensities on T1-W images, being
hypointense on T2-W images [49, 50, 51]. Finally,
micronodular biliary cirrhosis results from extensive
periductal and periductular ﬁbrosis associated with
sclerosing cholangitis [45, 46]. The segmental biliary
stenoses and asymmetrical dilatations can be detected by
conventional cholangiography (Fig. 6), or magnetic
resonance cholangiopancreatography (MRCP). At this
stage, liver transplantation is the treatment of choice
[45], which was performed in one of our patients.
LCH involvement of the gastrointestinal tract is very
rarely seen, as was the case in our study (n=2, 6%,
Table 1). It occurs in about 2% of systemic LCH in
large series [48, 52] and little is known about its clinical
course. However, it might be underdiagnosed because
digestive symptoms are very non-speciﬁc and are often
attributed to other aspects of the illness, such as side
eﬀects of the treatment [52]. According to Geissmann
et al. [48], it is always associated with multisystem dis-
ease and considered as one clinicopathological entity,
together with mucosal and cutaneous LCH, a feature
conﬁrmed by our two cases and by other published case
reports [15, 20, 53]. Thus children with cutaneous LCH
and digestive symptoms, such as malabsorption, diar-
rhoea or failure to thrive, should undergo gastrointes-
tinal tract biopsies [48].
The two cases with gastrointestinal involvement in
our study were proven by biopsy. One demonstrated
disease limited to the distal colon, while the other
showed histiocytic inﬁltration of the duodenal wall.
MRI detected nodular parietal thickening of the recto-
sigmoid in the ﬁrst case. Diagnostic procedures for the
second child were limited to gastroscopy and colonos-
copy with proof by biopsy. Unfortunately, neither could
be followed up long term.
Histopathologically, gastrointestinal LCH is charac-
terised by histiocytic inﬁltration of the lamina propria
and submucosa with consecutive irregular mucosal
thickening and erosions, followed by mucosal and
glandular atrophy [54]. On small bowel enema features,
LCH involvement is characterised by loss of the typical
mucosal pattern, appearance of the cobblestone feature,
segmental luminal narrowing and separation of loops
[5, 15, 48]. These radiological ﬁndings are generally
indistinguishable from those of other exudative enter-
opathies and inﬂammatory bowel diseases. Enlarged
mesenteric or other lymph nodes are not a particular
association [20, 48]. In our study, two children demon-
strated biopsy-proven histiocytic inﬁltration of the rec-
tum and sigmoid colon, one of whom had nodular
inﬁltration of distal colonic wall visible on CT. To our
knowledge there has not been any publication of the
Fig. 6 Biliary cirrhosis and sclerosing cholangitis due to LCH in a
3-year-old girl. Retrograde cholangiography demonstrates lack of
opaciﬁcation of the left intrahepatic bile ducts, while an arc-like
deviation and intraluminal irregularities are seen in the biliary
system of the right lobe
Fig. 5 a Abdominal CT on the same 3-year-old boy as in Fig. 4
depicts hepatosplenomegaly with multiple small hypodense nodules
disseminated throughout the liver parenchyma reﬂecting histiocytic
periportal inﬁltration. b Twelve months later, follow-up CT
demonstrates subtotal regression of the periportal inﬁltration with
persisting moderate hepatosplenomegaly and two focal hypoden-
sities in the left lobe of the liver. c However, CT 50 months later
demonstrates conﬂuent geographical hypodensities in the liver
parenchyma, this time without circumscribed nodules
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radiological ﬁndings of colonic involvement by LCH,
nor has there been any publication of the CT or MRI
features of histiocytic inﬁltration of small or large bowel.
However, they are very non-speciﬁc, similar to any
colitis of inﬂammatory, infectious or ischaemic origin.
Outcome is clearly related to extension of disease and
age of the child; intestinal dysfunction may persist for a
long time after treatment [48]. Clinical improvement
goes along with gradual reappearance of the mucosal
pattern on conventional bowel studies, which might still
be coarse [20].
Skin
Cutaneous LCH is very common, seen in 50% of all
cases [55] and conﬁrmed by our review. It is not neces-
sarily considered as a benign feature, as many patients
progress to disseminated disease, which is also true for
our study. Fifteen of 17 children with skin involvement
had multifocal extra-osseous LCH.
Rosai-Dorfman disease
In addition to the 31 children showing extra-osseous
LCH, our retrospective study revealed one 4-year-old
boy (Fig. 7) with another histiocytic syndrome which
occurs predominantly in children. RDD, or sinus his-
tiocytosis with massive lymphadenopathy, is a transi-
tional form between LCH and non-LCH pathologies. It
is an uncommon proliferative disorder of histiocytes, ﬁrst
described in 1969 [56]. Like LCH, the aetiology is still
unknown. It is generally thought to be a benign process,
a disorder of immune regulation or response to a pre-
sumed infectious agent. Major manifestations are seen in
the lymph nodes with resulting proliferation of sinusoi-
dal histiocytes [57]. The characteristic histological feature
is distension of sinusoids by histiocytes containing one or
more intact lymphocytes. Both Langerhans’ cells and the
histiocytes of RDD are S-110 protein positive, but the
latter do not contain Birbeck granules. The presence of
lymphophagocytic histiocytes and S-100 protein posi-
tivity is regarded as diagnostic of RDD [56, 57].
The most frequent clinical manifestation of RDD is
bilateral, non-tender, painless cervical lymphadenopathy
up to 6 cm in diameter. Extranodal multisystem disease
is rare and can be diﬃcult to diﬀerentiate from LCH [58,
59]. Our child showed orbital involvement expressed as
bilateral exophthalmos (Fig. 7a). Histologically, there
was diﬀuse histiocytic inﬁltration of retro-orbital fat.
Two treatments with corticosteroids led to temporary
regression, followed by local recurrence, which on the
second occasion was associated with hepatosplenomeg-
aly and retroperitoneal involvement (Fig. 7b). Bilateral
renal pelvic inﬂammatory masses resulting in extrinsic
ureteric and calyceal compression (Fig. 7c) extended to
the lumbar and sacral spine; there was inﬁltration of the
anterior epidural space and spinal foramina on both
sides from L1 to S2.
In general, RDD is considered as pseudotumoural
benign disease with self-limiting course. However,
aggressive behaviour has been reported, as in our child
who ﬁnally underwent surgery. The mortality is 7%,
mostly from complications and especially of the renal
system [57].
Fig. 7a–c A 4-year-old boy with extranodal multisystem Rosai
Dorfman disease. a Contrast-enhanced brain CT shows bilateral
expansive intraconal inﬁltration of retro-orbital fat by histiocytes.
The adjacent osseous structures, globes and optic nerves are
spared; the latter are surrounded by the inﬂammatory process. b
Abdominal CT demonstrates massive proliferation of histiocytes
within the hilus and pelvis of both kidneys with compression of
calyces and ureters. These features are also seen on intravenous
urography (c). There was concomitant invasion of the lumbar and
sacral spinal canal, including the anterior epidural space and both
foramina on MRI (not shown)
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Conclusions
There are very few publications concerning the various
radiological ﬁndings of all organs involved by LCH in
children, and the focus has been on osseous involvement
[25]. Extra-osseous LCH is characterised by many dif-
ferent possibilities for organ involvement, resulting in a
great variety of clinical manifestations and radiological
ﬁndings, none being pathognomonic in isolation. The
severity and pattern of the abnormality at the onset of
the disease, as well as monitoring of regression of tissue
inﬁltration, can be precisely monitored by the speciﬁc
imaging modalities currently available, e.g. MRI for
cerebral, osteoarticular and soft-tissue disease. MRCP
non-invasively detects inﬁltration of bile ducts and
additional sequences simultaneously evaluate hepatic
parenchyma. Spiral CT is still best indicated for
pulmonary and mediastinal lesions. HRCT may be a
substitute for RFT in assessing and monitoring the
extension of pulmonary involvement in LCH, especially
in very young children who are too small for reliable
RFT.
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